We demonstrated that among the three PPARs, PPAR-β/δ might be a strong target for lung fibrosis resolution compared to PPAR-α (minor effect) and PPAR-γ (additive effect with PPAR-β/δ under these experimental conditions, Table 2). The gene discussed is PPARG; the disease is pulmonary fibrosis.